Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/06/5a/df/065adfee-a7f1-da25-7540-a2646eda9449/mza_16158925352961033298.jpg/600x600bb.jpg
Frazis Capital Podcast
Michael Frazis
113 episodes
5 days ago
Michael Frazis, Misha Saul and guests discuss the life sciences, technology, and their latest investment ideas.
Show more...
Investing
Business
RSS
All content for Frazis Capital Podcast is the property of Michael Frazis and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Michael Frazis, Misha Saul and guests discuss the life sciences, technology, and their latest investment ideas.
Show more...
Investing
Business
https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded_nologo/1387964/1387964-1621055592219-d04d336721727.jpg
Clarity Pharmaceuticals, with Dr Alan Taylor
Frazis Capital Podcast
52 minutes 49 seconds
7 months ago
Clarity Pharmaceuticals, with Dr Alan Taylor

00:00 Welcome Back and Market Overview03:05 Navigating the Macro Environment05:59 Company Developments and Fast Track Designations09:11 Short Selling and Market Sentiment12:08 Innovations in PSMA Targeting Agents15:03 Financing Strategies and Market Positioning17:46 Clinical Trials and Sensitivity Improvements21:14 Regulatory Pathways and Market Entry24:00 Future Prospects and Market Dynamics35:30 Market Opportunities and Product Expansion35:59 Advancements in Diagnostics and Treatment39:03 Dose Optimization and Clinical Trials43:59 Patient Responses and Safety Profiles47:02 Future Directions and Phase Three Trials50:59 Navigating the Biotech Landscape52:47 Competitor Analysis and Market Positioning57:57 Innovations in Cancer Treatment

Frazis Capital Podcast
Michael Frazis, Misha Saul and guests discuss the life sciences, technology, and their latest investment ideas.